Hypoxia in breast cancer

Anna Maria Badowska-Kozakiewicz; Michał Piotr Budzik; Jacek Przybylski

doi:10.5114/pjp.2015.57245

eISSN: 2084-9869
ISSN: 1233-9687

Polish Journal of Pathology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2015
vol. 66

Send email

Copy url:

abstract:

Review paper

Hypoxia in breast cancer

Anna Maria Badowska-Kozakiewicz

,

Michał Piotr Budzik

,

Jacek Przybylski

Pol J Pathol 2015; 66 (4): 337-346

DOI: https://doi.org/10.5114/pjp.2015.57245

Online publish date: 2016/02/05

View full text Get citation

PlumX metrics:

Breast cancer continues to be one of the most common malignancies and is a serious problem particularly in women, although men may also be affected. Such lesions are commonly accompanied by hypoxia, and therefore hypoxia-dependent mechanisms, such as overexpression of hypoxia-inducible factor (HIF), the mechanisms are studied as part of the search for a novel method of cancer treatment. Blocking the activity of HIF and HIF-dependent molecular changes raises hopes for identification of a molecular target to inhibit the tumor growth or even to completely prevent its progression. However, this is difficult due to the crucial role HIF plays in numerous processes occurring not only in cancer cells but mostly in healthy systemic cells in physiological conditions.

keywords:

Hypoxia in breast cancer

Anna Maria Badowska-Kozakiewicz , Michał Piotr Budzik , Jacek Przybylski

hypoxia in cancer, breast cancer, HIF-1α

Anna Maria Badowska-Kozakiewicz

,

Michał Piotr Budzik

,

Jacek Przybylski